Reduced 11β-hydroxysteroid dehydrogenase type 2 activity is associated with decreased birth weight centile in pregnancies complicated by asthma

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 4, 2002, Pages 1660-1668

  Murphy, Vanessa E ^a,b   Zakar, Tamas ^a,b   Smith, Roger ^a,b   Giles, Warwick B ^a,b   Gibson, Peter G ^a,b   Clifton, Vicki L ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; BECLOMETASONE DIPROPIONATE; BUDESONIDE; ESTRIOL; FLUTICASONE PROPIONATE; GLUCOCORTICOID; HYDROCORTISONE; MESSENGER RNA; SALBUTAMOL; CORTICOTROPIN RELEASING FACTOR; HSD11B2 PROTEIN, HUMAN; HYDROXYSTEROID DEHYDROGENASE;

ARTICLE; ASTHMA; CORTICOSTEROID THERAPY; ENZYME ACTIVITY; FEMALE; HORMONE DETERMINATION; HUMAN; LOW BIRTH WEIGHT; PLACENTA FUNCTION; PREGNANCY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ADULT; BIRTH WEIGHT; BLOOD; ENZYMOLOGY; FETUS BLOOD; GENETICS; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; PLACENTA; PREGNANCY COMPLICATION;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ADMINISTRATION, INHALATION; ADULT; ASTHMA; BIRTH WEIGHT; CORTICOTROPIN-RELEASING HORMONE; FEMALE; FETAL BLOOD; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASES; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; RNA, MESSENGER;

EID: 0036016617     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.87.4.1660     Document Type: Article

References (50)

1. The relationship between asthma and smoking during pregnancy
2. Asthma in pregnancy
3. The course and outcome of pregnancy in women with bronchial asthma
4. Outcome of pregnancy in women requiring corticosteroids for severe asthma
5. Labour and delivery in mothers with asthma
6. Asthma in pregnancy
7. Infant and maternal outcomes in the pregnancies of asthmatic women
8. Possible role of asthma in the risk of preterm labor and delivery
9. Maternal asthma, premature birth, and the risk of respiratory morbidity in schoolchildren in Merseyside
10. Asthma treatment in pregnancy: A randomized controlled study
11. Fetal morbidity following potentially anoxigenic obstetric conditions. VII. Bronchial asthma
12. Asthma and pregnancy: A prospective study of 198 pregnancies
13. Perinatal outcomes in women with asthma during pregnancy
14. Ratio of cortisone/cortisol in mother and infant at birth
15. Immunohistochemical localization of the 11β-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta
16. Differential expression of 11β-hydroxysteroid dehydrogenase types 1 and 2 in human placenta and fetal membranes
17. Expression of 11β-hydroxysteroid dehydrogenase isozymes and corticosteroid hormone receptors in primary cultures of human trophoblast and placental bed biopsies
18. 11β-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction
19. Reduced placental 11β-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: An analysis of possible mechanisms
20. 11β-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess
21. The use of continuous quality improvement methods to implement practice guidelines in asthma
22. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
23. Differential regulation of 11β-hydroxysteroid dehydrogenase type 1 and 2 by nitric oxide in cultured human placental trophoblast and chorionic cell preparation
24. Differential stimulation of protein kinase C activity by phorbol ester or calcium/phosphatidylserine in vitro and in intact synaptosomes
25. Interrelationships between asthma and pregnancy: A literature review
26. Intrauterine growth is related to gestational pulmonary function in pregnant asthmatic women
27. The outcome of pregnancy complicated by severe asthma
28. Effect of bronchial asthma on the course of pregnancy, labour and perinatal outcome
29. Acute asthma during pregnancy
30. Modulation of 11β-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: An autocrine switch from glucocorticoid inactivation to activation
31. Prostaglandins and leukotriene B4 are potent inhibitors of 11β-hydroxysteroid dehydrogenase type 2 activity in human choriocarcinoma JEG-3 cells
32. Malaria elicits type 1 cytokines in the human placenta: IFN-g and TNF-a associated with pregnancy outcomes
33. Malaria and pregnancy: Placental cytokine expression and its relationship to intrauterine growth retardation
34. Inflammatory bowel disease: A controlled study of late pregnancy outcome
35. Obstetrical and neonatal outcome in pregnant patients with rheumatic disease
36. Pregnancy outcome for women with Crohn's disease: A follow-up study based on linkage between national registries
37. Pregnancy in patients with systemic lupus erythematosus
38. Increased risk of preterm birth for women with inflammatory bowel disease
39. Repeated antenatal corticosteroids: Size at birth and subsequent development
40. Effects of repeated maternal betamethasone administration on growth and hypothalamic-pituitary-adrenal function of the ovine fetus at term
41. Regulation of 11β-hydroxysteroid dehydrogenase type 2 by steroid hormones and epidermal growth factor in the Ishikawa human endometrial cell line
42. Rat 11β-hydroxysteroid dehydrogenase type 2 enzyme is expressed at low levels in the placenta and is modulated by adrenal steroids in the kidney
43. Differential regulation of 11β hydroxysteroid dehydrogenase (HSD) types 1 and 2 by betamethasone in baboon chorion and placenta
44. Developmental and functional biology of the primate fetal adrenal cortex
45. Perinatal complications associated with maternal tobacco use
46. Glucocorticoid exposure in utero: New model for adult hypertension
47. Type 2 11β-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: Its relationship to birth weight and putative role in fetal adrenal steroidogenesis
48. Variation in placental type 2 11β-hydroxysteroid dehydrogenase activity is not related to birth weight or placental weight